![Lee Arnold](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lee Arnold
Corporate Officer/Principal bei
Institute of Chemical Biology & Drug Discovery
Profil
Lee D.
Arnold is the founder of Discoverelucidations LLC, founded in 2007, serving as President & Chief Executive Officer from 2007 to 2018.
Dr. Arnold was the founder of Pardes Biosciences, Inc., founded in 2020, serving as Chief Scientific Officer from 2020 to 2022.
Dr. Arnold currently holds the position of Member at the Institute of Chemical Biology & Drug Discovery.
Former jobs include Vice President-Research at OSI Pharmaceuticals, Inc. in 2007; Principal at Pfizer Inc.; Principal at Syntex Corp.; Chief Scientific Officer & Vice President at BlinkBio, Inc. from 2009 to 2014; Chief Scientific Officer at Aethlon Medical, Inc. from 2023 to 2024; Principal at AbbVie Bioresearch Center, Inc.; Chief Discovery Officer at Assembly Biosciences, Inc. in 2016; and Senior Vice President-Research at Kinnate Biopharma, Inc. from 2018 to 2020.
Education includes a doctorate from the University of Alberta and an undergraduate degree from The University of Waterloo.
Aktive Positionen von Lee Arnold
| Unternehmen | Position | Beginn |
|---|---|---|
Institute of Chemical Biology & Drug Discovery | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Lee Arnold
| Unternehmen | Position | Ende |
|---|---|---|
| AETHLON MEDICAL, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2024 |
| PARDES BIOSCIENCES, INC. | Gründer | 01.10.2022 |
| KINNATE BIOPHARMA INC. | Corporate Officer/Principal | 01.04.2020 |
Discoverelucidations LLC | Vorstandsvorsitzender | 01.04.2018 |
| ASSEMBLY BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 |
Ausbildung von Lee Arnold
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
38
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Syntex Corp.
 Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Aethlon Medical, Inc.
 Aethlon Medical, Inc. Medical SpecialtiesHealth Technology Provides diagnostic and therapeutic device solutions for infectious disease, cancer & for other life threatening conditions | Health Technology |
BlinkBio, Inc.
 BlinkBio, Inc. Pharmaceuticals: MajorHealth Technology Develops orally active drugs that act like small drug molecules | Health Technology |
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Waterloo
 The University of Waterloo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AbbVie Bioresearch Center, Inc.
 AbbVie Bioresearch Center, Inc. BiotechnologyHealth Technology Provides drug discovery, development sciences and biologics research services | Health Technology |
Discoverelucidations LLC | |
Assembly Biosciences, Inc.
 Assembly Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of products for infectious diseases | Health Technology |
Institute of Chemical Biology & Drug Discovery | |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage precision oncology company | Health Technology |
Pardes Biosciences, Inc.
 Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral antiviral treatment for COVID-19 | Health Technology |
